{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:25:38Z","timestamp":1784741138699,"version":"3.55.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.ijantimicag.2012.11.016","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T15:40:57Z","timestamp":1357746057000},"page":"288-291","source":"Crossref","is-referenced-by-count":18,"title":["In vitro susceptibility of European human Borrelia burgdorferi sensu stricto strains to antimicrobial agents"],"prefix":"10.1016","volume":"41","author":[{"given":"Gorana","family":"Veinovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tja\u0161a","family":"Cerar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franc","family":"Strle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanka","family":"Lotri\u010d-Furlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Maraspin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u017ee","family":"Cimperman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Ru\u017ei\u0107-Sablji\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2012.11.016_bib0005","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","article-title":"Lyme borreliosis","volume":"379","author":"Stanek","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2012.11.016_bib0010","first-page":"911","article-title":"Principles of the diagnosis and antibiotic treatment of Lyme borreliosis","volume":"111","author":"Strle","year":"1999","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.ijantimicag.2012.11.016_bib0015","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1128\/JCM.30.10.2692-2697.1992","article-title":"In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies","volume":"30","author":"Dever","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2012.11.016_bib0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0924-8579(00)00116-3","article-title":"Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates","volume":"15","author":"Hunfeld","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.11.016_bib0025","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1128\/AAC.34.11.2133","article-title":"Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents","volume":"34","author":"Johnson","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.11.016_bib0030","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1128\/AAC.37.7.1444","article-title":"In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents","volume":"37","author":"Levin","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.11.016_bib0035","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijantimicag.2005.02.007","article-title":"Susceptibility of Borrelia afzelii strains to antimicrobial agents","volume":"25","author":"Ru\u017ei\u0107-Sablji\u0107","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.11.016_bib0040","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1128\/JCM.41.4.1791-1793.2003","article-title":"In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto","volume":"41","author":"Sicklinger","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2012.11.016_bib0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0934-8840(11)80890-X","article-title":"In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: influence of test conditions on minimal inhibitory concentration (MIC) values","volume":"283","author":"Boerner","year":"1995","journal-title":"Zentralbl Bakteriol"},{"key":"10.1016\/j.ijantimicag.2012.11.016_bib0050","series-title":"Manual of clinical microbiology","first-page":"1108","article-title":"Susceptibility test methods: dilution and disk diffusion methods","author":"Jorgensen","year":"2003"},{"key":"10.1016\/j.ijantimicag.2012.11.016_bib0055","series-title":"Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. Document M100-S20","author":"Clinical and Laboratory Standards Institute","year":"2010"},{"issue":"Suppl 6","key":"10.1016\/j.ijantimicag.2012.11.016_bib0060","doi-asserted-by":"crossref","first-page":"S1518","DOI":"10.1093\/clinids\/11.Supplement_6.S1518","article-title":"A perspective on the treatment of Lyme borreliosis","volume":"11","author":"Luft","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.11.016_bib0065","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF01781096","article-title":"Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants","volume":"24","author":"Preac-Mursic","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2012.11.016_bib0070","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1128\/AAC.40.6.1552","article-title":"Eucaryotic cells protect Borrelia burgdorferi from the action of penicillin and ceftriaxone but not from the action of doxycycline and erythromycin","volume":"40","author":"Brouqui","year":"1996","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912004530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912004530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T02:43:46Z","timestamp":1595213026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857912004530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0924857912004530"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.11.016","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}